Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $6.7200 (-7.69%) ($6.6700 - $6.7200) on Tue. Apr. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.55% (three month average) | RSI | 16 | Latest Price | $6.7200(-7.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -3.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -9.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(47%) IBB(45%) ARKK(44%) ARKG(43%) XAR(41%) | Factors Impacting ATRA price | ATRA will decline at least -2.275% in a week (0% probabilities). VIXM(-39%) VXX(-26%) UNG(-18%) USO(-11%) TLT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.275% (StdDev 4.55%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-12.01(-278.72%) | Resistance Level | $8.4 | 5 Day Moving Average | $7.29(-7.82%) | 10 Day Moving Average | $7.64(-12.04%) | 20 Day Moving Average | $8.4(-20%) | To recent high | -57.1% | To recent low | 0% | Market Cap | $499m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |